These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20398561)

  • 1. [Atorvastatin use and coronary flow reserve in patients with coronary slow flow].
    Fan Y; Yang SS; Yu JB; Hao JH; Han W; Gan RT; Wang Z; Li WM; Huang YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Feb; 38(2):143-6. PubMed ID: 20398561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow.
    Caliskan M; Erdogan D; Gullu H; Topcu S; Ciftci O; Yildirir A; Muderrisoglu H
    Clin Cardiol; 2007 Sep; 30(9):475-9. PubMed ID: 17803205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of two intensive statin regimens on progression of coronary disease.
    Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE
    N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease.
    Wielepp P; Baller D; Gleichmann U; Pulawski E; Horstkotte D; Burchert W
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1371-7. PubMed ID: 16133398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin treatment improves myocardial and peripheral blood flow in familial hypercholesterolemia subjects without evidence of coronary atherosclerosis.
    Lario FC; Miname MH; Tsutsui JM; Santos RD; Kowatsch I; Sbano JC; Ramires JA; Kalil Filho R; Mathias W
    Echocardiography; 2013 Jan; 30(1):64-71. PubMed ID: 22957727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function.
    Eshtehardi P; McDaniel MC; Dhawan SS; Binongo JN; Krishnan SK; Golub L; Corban MT; Raggi P; Quyyumi AA; Samady H
    J Invasive Cardiol; 2012 Oct; 24(10):522-9. PubMed ID: 23043036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of different statin regimens on lipid profile and serum metalloproteinases in patients with coronary heart disease].
    Liang W; Yang H; Wu CF; Yu Q; Zhang DD; Lu GP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 May; 37(5):417-21. PubMed ID: 19781217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy of candesartan with statin inhibits progression of atherosclerosis more than statin alone in patients with coronary artery disease.
    Suzuki T; Nozawa T; Fujii N; Sobajima M; Ohori T; Shida T; Matsuki A; Kameyama T; Inoue H
    Coron Artery Dis; 2011 Aug; 22(5):352-8. PubMed ID: 21494127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) study.
    Farsang C; Athyros V; Gaw A;
    Curr Med Res Opin; 2007 Aug; 23(8):1945-56. PubMed ID: 17626713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
    Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
    N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification].
    Li XP; Duan J; Zhao SP; Tan MY; Xu ZM; Zhang DQ
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2399-403. PubMed ID: 17156651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with noninvasive coronary flow reserve in severe aortic stenosis.
    Meimoun P; Germain AL; Elmkies F; Benali T; Boulanger J; Espanel C; Clerc J; Zemir H; Luycx-Bore A; Tribouilloy C
    J Am Soc Echocardiogr; 2012 Aug; 25(8):835-41. PubMed ID: 22742867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography.
    Hinoi T; Matsuo S; Tadehara F; Tsujiyama S; Yamakido M
    Am J Cardiol; 2005 Jul; 96(1):89-91. PubMed ID: 15979441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients 'on' and 'off' atorvastatin for short time intervals.
    Thomas MK; Narang D; Lakshmy R; Gupta R; Naik N; Maulik SK
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):37-44. PubMed ID: 16534549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
    Shukla A; Sharma MK; Jain A; Goel PK
    Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.
    Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2465-72. PubMed ID: 25212234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of carvedilol on coronary flow reserve in patients with dilated cardiomyopathy].
    Fan Y; Lin JH; Dong G; Zhu J; Yin F; Yang SS
    Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):217-9. PubMed ID: 20450653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.